NIVI Development is a mission-driven organization enabling the translation of vaccine discoveries into preclinical and early clinical development. We bring together leading researchers, vaccine and business developers, and strategic partners to catalyze the progression of promising vaccine candidates.
NIVI Development is part of the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) – a unique ecosystem and public-private partnership working toward a shared mission to advance vaccines that provide robust, durable, and broad protection against respiratory pathogens.
Respiratory pathogens are a major public health threat. Airborne diseases spread quickly and unpredictably, and many high-risk respiratory pathogens still lack vaccines that provide strong, durable protection where it is needed most – in the airways.
New, innovative approaches are required to counteract existing pathogens, as well as new pandemic threats and the rise in antimicrobial resistance. NIVI was created to rise to this challenge and translate research and innovation into new vaccines, better preparedness, and global impact.
NIVI brings together leading experts in immunology and vaccine development from Denmark and around the world to develop vaccine candidates against some of the most important and deadly respiratory pathogens. In so doing, NIVI aims to create a knowledge hub in airway immunity and establish vaccine development pipelines that can be rapidly adapted to respond to new emerging pathogens. The three target pathogens for NIVI are influenza, tuberculosis, and group A streptococcus. NIVI stands out not only for its scientific ambition, but for its structure: a uniquely integrated ecosystem designed to bridge academic discovery and vaccine development.
NIVI-Research Center is an academic research center anchored at the University of Copenhagen that works in close collaboration with Statens Serum Institut as a key partner. The Research Center is responsible for the research, discovery and educational aspects of the NIVI initiative.
Read moreNIVI Development enables the translational ambitions of NIVI by providing dedicated expertise in vaccine development, preclinical and early clinical progression, innovative clinical trial approaches, and strategic partnerships and alliances to advance new vaccine candidates.